Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness.

Shekelle P, Morton S, Atkinson S, Suttorp M, Tu W, Heidenreich P, Gubens M, Maglione M, Jungvig L, Roth E, Newberry S.

Evid Rep Technol Assess (Summ). 2003 Jul;(82):1-6. No abstract available.

2.

Role of race in the pharmacotherapy of heart failure.

Kalus JS, Nappi JM.

Ann Pharmacother. 2002 Mar;36(3):471-8. Review.

PMID:
11895062
3.

Beta-blockade in chronic heart failure: does it work in everyone?

Chahoud G, Joseph J.

Curr Opin Cardiol. 2003 Sep;18(5):400-5. Review.

PMID:
12960474
4.

Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.

Andersson F, Cline C, Rydén-Bergsten T, Erhardt L.

Pharmacoeconomics. 1999 Jun;15(6):535-50. Review.

PMID:
10538327
5.

[Treatment of heart failure due to systolic dysfunction].

Jiménez-Navarro MF, García-Pinilla JM, Montiel Trujillo A, de Teresa Galván E.

Rev Esp Cardiol. 2006 Jul;6 Suppl F:46-52. Review. Spanish.

PMID:
17144976
6.

The treatment of chronic heart failure due to left ventricular systolic dysfunction.

Gardner RS, McDonagh TA.

Clin Med (Lond). 2004 Jan-Feb;4(1):18-22. Review. No abstract available.

PMID:
14998261
7.

Sex-related differences in heart failure and beta-blockers.

Ghali JK.

Heart Fail Rev. 2004 Apr;9(2):149-59. Review.

PMID:
15516863
8.
9.

[Neurohumoral blocking agents].

Kurisu S, Kihara Y.

Nihon Rinsho. 2011 Nov;69 Suppl 9:394-6. Review. Japanese. No abstract available.

PMID:
22724235
10.
11.

The pharmacological management of heart failure: too many treatments?

van Veldhuisen DJ, van Gilst WH.

Eur J Heart Fail. 2003 Jan;5(1):5-8. Review. No abstract available.

12.

Clinical trials of beta-blockers in heart failure: a class review.

Yancy CW.

Am J Med. 2001 Apr 2;110 Suppl 5A:7S-10S. Review.

PMID:
11259751
13.

[Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].

Kubota T, Takeshita A.

Nihon Rinsho. 2003 May;61(5):801-6. Review. Japanese.

PMID:
12755006
14.

Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy.

Kazi D, Deswal A.

Heart Fail Clin. 2005 Apr;1(1):25-37. Epub 2005 Jan 7. Review. No abstract available.

PMID:
17386831
15.

Should beta-blockers form the cornerstone for the treatment of congestive heart failure?

Tabrizchi R.

Expert Rev Cardiovasc Ther. 2003 Jul;1(2):157-60. Review. No abstract available.

PMID:
15030275
16.
17.

Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.

Parra D, Marshall R, Soisson K.

Lippincotts Prim Care Pract. 1999 May-Jun;3(3):316-32. Review.

PMID:
10711133
18.

Beta-blockers in left ventricular systolic dysfunction--from evidence to practice.

Bandyopadhyay S, O'Mahony MS.

Age Ageing. 2002 Jan;31(1):23-8. Review.

PMID:
11850304
19.

The role of race in heart failure therapy.

Yancy CW.

Curr Cardiol Rep. 2002 May;4(3):218-25. Review.

PMID:
11960591
20.

Drug therapy of heart failure in the elderly.

Rich MW.

Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):235-42. Review.

PMID:
12888704

Supplemental Content

Support Center